Gabapentin Tablet
Product Images NDC 71335-2048
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Gabapentin-fig1 (Gabapentin Fig1)
The text suggests a study or experiment that involves a four-week dose titration period and a four-week fixed dose period. The two options explored are placebo and Gabapentin, with a maximum dosage of 3600 mg/day. The text also provides a mean pain score of 10, but it is unclear what this score refers to without additional context.*
Gabapentin-fig2 (Gabapentin Fig2)
This text is indicating a table that shows the mean pain score for different groups in a study, with different dosages and placebo. The study lasts for four weeks, with a baseline at the beginning and measurements taken at week one. The text is not complete and there is no further information available.*
Gabapentin-fig3 (Gabapentin Fig3)
Gabapentin-fig4 (Gabapentin Fig4)
Gabapentin-structure (Gabapentin Structure)
Label (Lbl713352048)
This text appears to be a product label information for a tablet called "Neurontin 600mg" packaged by Bryant Ranck Prepack. The manufacturer is Alkem Laboratories Limited and the package contains 90 tablets which expire in a specific month and year. The NDC number mentioned is 7133520481. The tablet should be stored at room temperature and kept away from children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.